Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER study.
Dave SinghAida EmirovaCatherine FranciscoDebora SantoroMirco GovoniMarie Anna NandeuilPublished in: Respiratory research (2020)
ClinicalTrials.gov ( NCT02986321 ). Registered 8 Dec 2016.